|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. It focuses on improving cancer diagnostics, particularly hematologic malignancies. Its objective is to enhance diagnostic accuracy and accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, and Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division and the Products Division. |
| 公司地址
| 4 Science Park, New Haven, CT, USA, 06511 |
| 電話號碼
| +1 203 787-7888 |
| 傳真號碼
| +1 203 901-1289 |
| 公司網頁
| https://www.precipiodx.com |
| 員工數量
| 71 |
| Mr. Ahmed Zaki Sabet |
Chief Operating Officer |
美元 200.00K |
30/03/2026 |
| Dr. Ayman A. Mohamed, M.D. |
Chief Technology Officer |
美元 200.00K |
30/03/2026 |
| Mr. Ilan Danieli |
Director and Chief Executive Officer |
美元 300.00K |
30/03/2026 |
| Mr. Matthew Gage |
Chief Financial Officer and Principal Accounting Officer |
-- |
30/03/2026 |
|
|
| Mr. David S. Cohen |
Independent Director |
30/03/2026 |
| Dr. Jeffrey Cossman, M.D. |
Independent Director |
30/03/2026 |
| Mr. Richard A. Sandberg |
Chairman of the Board |
30/03/2026 |
| Mr. Ilan Danieli |
Director and Chief Executive Officer |
30/03/2026 |
| Mr. Ronald A. Andrews, Jr |
Independent Director |
30/03/2026 |
| Ms. Christina Valauri |
Independent Director |
30/03/2026 |
| Ms. Kathleen D. Laporte |
Independent Director |
30/03/2026 |
|
|
|
|
